Sagent Pharm Inc (SGNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2011 | 03-2011 | 12-2010 | 09-2010 | 06-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -12,566 | -4,371 | -24,495 | -20,888 | -16,026 |
| Depreciation Amortization | 546 | 203 | 1,230 | 782 | 564 |
| Accounts receivable | -2,661 | -977 | -12,068 | -1,102 | -579 |
| Other Working Capital | -13,597 | -13,645 | -7,776 | -4,363 | -4,575 |
| Other Operating Activity | 5,747 | 2,594 | 15,312 | 3,249 | 2,149 |
| Operating Cash Flow | $-22,531 | $-16,196 | $-27,797 | $-22,322 | $-18,467 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -113 | -6 | -345 | -193 | -8 |
| Purchase Of Investment | -49,459 | -17 | -5,192 | -5,065 | -4,980 |
| Sale Of Investment | 924 | 670 | N/A | N/A | N/A |
| Purchase Sale Intangibles | -603 | -70 | -1,839 | -579 | -257 |
| Other Investing Activity | -1,066 | 51 | -1,739 | -997 | -31 |
| Investing Cash Flow | $-49,714 | $698 | $-7,276 | $-6,255 | $-5,019 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 15,000 | 15,000 | N/A | N/A | N/A |
| Common Stock Issued | 101,573 | 561 | 217 | 136 | 12 |
| Other Financing Activity | -698 | -2,023 | 61,501 | 50,332 | 39,299 |
| Financing Cash Flow | $115,875 | $13,538 | $61,718 | $50,468 | $39,311 |
| Beginning Cash Position | 34,376 | 34,376 | 7,731 | 7,731 | 7,731 |
| End Cash Position | 78,006 | 32,416 | 34,376 | 29,622 | 23,556 |
| Net Cash Flow | $43,630 | $-1,960 | $26,645 | $21,891 | $15,825 |
| Free Cash Flow | |||||
| Operating Cash Flow | -22,531 | -16,196 | -27,797 | -22,322 | -18,467 |
| Capital Expenditure | -113 | -6 | -345 | -193 | -8 |
| Free Cash Flow | -22,644 | -16,202 | -28,142 | -22,515 | -18,475 |